Vienna Pure ImagingAi-powered tomographic 3D ultrasound inventing a medical device agency has announced the successful completion of € 5.6 million growth capital funding round today.
The round was led by a leading healthcare investment in Germany, the Asves Capital Partners.
“Ultrasound is one of the most valuable imaging methods – flexible, safe and affordable. However its largest restriction goes from user-dependent, because most decisions are drawn from the 2D slices changed by the operator“Said Frederick BenderManaging Director and CEO of Pure Imaging. “By adding the third dimension, we are mostly deleted-extensively from the subcogical snapshots, transferred to organ-level imaging that enables AI to make a more continuous and reliable analysis.
“THis investment let us bring this aspect scale. It gives us the ability to increase our commercial footprints, especially in the United States, extends our products with global ultrasound leaders and continues to develop clinical applications that improve the patient’s results. We’re not simply adding technology – we’re changing the quality of careThe “
Established in 2014, Pure Imaging is an ISO -13485 certified and FDA -Covered Medical Device Company, specialized in advanced tomographic 3D ultrasound solutions. Their mission is to improve diagnostic workflies and increase the patient care by providing innovative add-on solutions for existing ultrasound devices, empowering physicians with proper, reproductive imaging for the best patient results.
Censor-owned sensor standard 2D ultrasound systems converted to high-performe 3D Imaging platforms-enable the Puro organ and physiological structure to capture a single scan. AI-based image analysis and volumetric measurement, this progress gives physicians the ability to provide rapid, more motivational and more reproductive diagnosis across the wide range of clinical applications of physicical applications.
“Pure’s view is elegant in its simplicity. Instead of re-inventing the wheel, they unlock new values with existing ultrasound systems, with non-ad-on solutions,“Said ChristopheInvestment Principal in Eskvent Capital Partners. “It reduces the obstacle to taking it significantly – users understand it immediately and clear the clinical facilitiesThe “
After the recent FDA exemption and the establishment of the US -Assistant Agency, the new funds will increase the commercial expansion of the company, especially in the United States.
Growth will be powered by two key products: Pure Tus Infinity, a seller-neutral ad-on that turns an existing 2D ultrasound into a 3D device and inside the pure tust, an integrated solution is embedded in directly selected GE Health Care Scanners.
“What provokes us as an investor is a standard proposal and the focus of the strong Foundation of the organization. Pure has already created a loyal customer base in the Dutch region, signed a contract with respected partners in the imaging ecosystem, and combined a team with a central aspect for scaling across clinical indicators and geographies.
“The recent FDA exemption of Inside TUs as an ideal time for investment, the main regulatory milestone perfectly aligns with our technique to target the opportunity to reach the milestone” Bartosc Associated
Since the world’s healthcare systems try to improve diagnostic access and skills, Pure’s Tomographic 3D Alt Rasound answers a potential converter.
[publish_date
